13 Jul 2023
13 Jul 2023
22 Jun 2023
11 May 2023
02 May 2023
Analysis shows patients treated with CroFab® require fewer total vials of antivenom, and fewer administrations to achieve control, than Anavip.
15 Mar 2023
Model simulation shows cost of timely Voraxaze® use is offset by shorter hospital stays and associated with substantially improved clinical outcomes